Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
INDUSTRY
×
Abituzumab
×
Clear all
Filters
3
NCT03688230
2020-03-18
AMELION
SFJ Pharmaceuticals, Inc.
Phase 2
Withdrawn
NCT01360840
2015-12-14
PERSEUS
EMD Serono
Phase 2
Completed
180 enrolled
23 charts